Actavis Names Maria Teresa Hilado Chief Financial Officer


- Expertise in global finance, M&A, business development -

- Will join Actavis effective December 8, 2014 -



Nov. 10, 2014

/PRNewswire/ --

Actavis plc

(NYSE: ACT), a leading global specialty pharmaceutical company, today announced that

Maria Teresa (Tessa) Hilado

will join the Company, effective

December 8, 2014

, as Chief Financial Officer.

Ms. Hilado brings more than 26 years of global finance experience to the position, and will be based at the Company's

Parsippany, NJ

, U.S. Administrative Headquarters. She will succeed

R. Todd Joyce

, who will remain with


through early 2015 to support the transition.

"Tessa is an experienced, finance leader whose nearly three decades in financial leadership roles at some of the world's leading multinational corporations will be invaluable to


as we continue our evolution as one of the fastest-growing and most dynamic pharmaceutical companies in the world," said

Brent Saunders



CEO and President. "She will bring extensive expertise in global finance, mergers and acquisitions and business development, and is widely recognized for her exceptional leadership skills. We are excited to add a senior executive of Tessa's caliber to



Ms. Hilado joins



PepsiCo, Inc.

, where she has served as Senior Vice President, Finance and Treasurer since 2009. Prior to


, she served as Vice President and Treasurer for

Schering-Plough Corporation

from 2008 to 2009. Ms. Hilado spent more than 17 years with

General Motors Corporation

, in a variety of increasingly responsible positions most notably Assistant Treasurer from 2006 to 2008, and previously

CFO GMAC Commercial Finance LLC

from 2001 to 2005. She also held positions in the capital markets, business development, worldwide funding and pension analysis and overseas financing functions. She began her career with

Far East Bank and Trust Company


Manila, Philippines


Ms. Hilado serves on the Board of Directors of

H.B. Fuller

, and previously served on the Board of Directors of Bausch & Lomb. She earned a Master's in Business Administration from the

University of Virginia's

Darden School of Business Administration

, and a Bachelor of Science in Management Engineering from

Ateneo de Manila University


the Philippines




Actavis plc

(NYSE:ACT), headquartered in

Dublin, Ireland

, is a unique specialty pharmaceutical company focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world.


markets a broad portfolio of branded and generic pharmaceuticals and develops innovative medicines for patients suffering from diseases principally in the central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory and anti-infective therapeutic categories. The company is an industry leader in product research and development, with one of the broadest brand development pipelines in the pharmaceutical industry, and a leading position in the submission of generic product applications.


has commercial operations in more than 60 countries and operates more than 30 manufacturing and distribution facilities around the world.

For more information, visit


website at

Actavis Forward-Looking Statement

Statements contained in this communication that refer to


estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-looking statements that reflect


current perspective of existing trends and information as of the date of this communication. Actual results may differ materially from


current expectations depending upon a number of factors affecting


business. These factors include, among others, the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and regulatory agency approvals or actions, if any; market acceptance of and continued demand for


products; difficulties or delays in manufacturing; and such other risks and uncertainties detailed in


periodic public filings with the

Securities and Exchange Commission

, including but not limited to

Actavis plc's

Annual Report on Form 10-K for the year ended

December 31, 2013

, Quarterly Report on Form 10-Q for the quarter ended

September 30, 2014

and from time to time in


other investor communications. Except as expressly required by law,


disclaims any intent or obligation to update or revise these forward-looking statements.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.